I'm curious what you think about manufacturing CAR-Ts at scale? There are a number of companies working on automating as much of the process as possible (Lonza, Cellares, Multiply Labs, etc), I'd be interested in your opinion on the issue and what you think the best solutions are.
Thanks for such a relevant question. There are some major changes happening in the manufacturing of CAR-Ts and automation is one of them. Automation will help to minimise the batch effects, reduce the production time and hopefully bring down the cost of therapy.
Your question has inspired me to write an article on the companies working on improvising the manufacturing of CAR-Ts. Thanks again.
I'm curious what you think about manufacturing CAR-Ts at scale? There are a number of companies working on automating as much of the process as possible (Lonza, Cellares, Multiply Labs, etc), I'd be interested in your opinion on the issue and what you think the best solutions are.
Hi Andrew, Sorry for late reply.
Thanks for such a relevant question. There are some major changes happening in the manufacturing of CAR-Ts and automation is one of them. Automation will help to minimise the batch effects, reduce the production time and hopefully bring down the cost of therapy.
Your question has inspired me to write an article on the companies working on improvising the manufacturing of CAR-Ts. Thanks again.